This investment will facilitate the company's move to a larger, advanced office facility in the Greater Toronto Area, Ontario. This new investment is part of AstraZeneca's global goal to achieve ...
Invest Ontario is partnering with AstraZeneca (AZN) to expand the company’s global R&D hub in Mississauga. This C$820M investment underscores Ontario’s growing prominence in the life sciences ...
AstraZeneca has unveiled plans to invest around ... AZ announced a C$500 million investment in its Global Clinical Hub in Mississauga, Ontario, to expand its research and clinical trials ...
The investment comes after AstraZeneca last year completed its C$3 billion acquisition of Hamilton, Ontario-based Fusion Pharmaceuticals, which is developing next-generation radioconjugates ...